BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23658847)

  • 1. Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
    Yeboah-Manu D; Kpeli GS; Ruf MT; Asan-Ampah K; Quenin-Fosu K; Owusu-Mireku E; Paintsil A; Lamptey I; Anku B; Kwakye-Maclean C; Newman M; Pluschke G
    PLoS Negl Trop Dis; 2013; 7(5):e2191. PubMed ID: 23658847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.
    Schütte D; Um-Boock A; Mensah-Quainoo E; Itin P; Schmid P; Pluschke G
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e2. PubMed ID: 17989779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
    Tanywe A; Fernandez RS
    JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
    Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
    Chauty A; Ardant MF; Adeye A; Euverte H; Guédénon A; Johnson C; Aubry J; Nuermberger E; Grosset J
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4029-35. PubMed ID: 17526760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease.
    Sarfo FS; Phillips R; Asiedu K; Ampadu E; Bobi N; Adentwe E; Lartey A; Tetteh I; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3678-85. PubMed ID: 20566765
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kwofie SK; Dankwa B; Odame EA; Agamah FE; Doe LPA; Teye J; Agyapong O; Miller WA; Mosi L; Wilson MD
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29954088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease.
    Warryn L; Pluschke G
    Chimia (Aarau); 2023 Sep; 77(9):577-581. PubMed ID: 38047833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buruli Ulcer Disease and Its Association with Land Cover in Southwestern Ghana.
    Wu J; Tschakert P; Klutse E; Ferring D; Ricciardi V; Hausermann H; Oppong J; Smithwick EA
    PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003840. PubMed ID: 26091265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buruli ulcer in a nine-month-old boy.
    Tsukagoshi S; Dehn TC
    Ann R Coll Surg Engl; 2012 Oct; 94(7):e215-6. PubMed ID: 23031753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Management Strategies for Buruli Ulcers.
    Popa GL; Muntean AA; Popa MI
    Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof-of-principle trial.
    Junghanss T; Um Boock A; Vogel M; Schuette D; Weinlaeder H; Pluschke G
    PLoS Negl Trop Dis; 2009; 3(2):e380. PubMed ID: 19221594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stigma experiences, effects and coping among individuals affected by Buruli ulcer and yaws in Ghana.
    Tuwor RD; Mtuy TB; Amoako YA; Owusu L; Oppong MN; Agbanyo A; Agbavor B; Marks M; Walker SL; Yeboah-Manu D; Pullan RL; Dapaah JM; Phillips RO; Palmer J;
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012093. PubMed ID: 38683858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and microbiological predictors of healing in Buruli ulcer disease.
    Agbavor B; Agbanyo A; Loglo AD; Antwi PB; Ackam N; Adjei J; Frimpong V; Boampong K; Frimpong M; Addo MG; Wansbrough-Jones M; Amoako YA; Phillips RO
    J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100415. PubMed ID: 38292054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium ulcerans-Bordetella trematum chronic tropical cutaneous ulcer: A four-case series, Côte d'Ivoire.
    Tchan BGO; Kakou-Ngazoa S; Dizoe S; Hammoudi N; Grine G; Ruimy R; Drancourt M
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011413. PubMed ID: 38060465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research article network analysis of polymicrobial chronic wound infections in Masanga, Sierra Leone.
    Sandmann S; Nunes JV; Grobusch MP; Sesay M; Kriegel MA; Varghese J; Schaumburg F
    BMC Infect Dis; 2023 Apr; 23(1):250. PubMed ID: 37072717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold Panning-Related Chronic Cutaneous Ulcers in Guinea, West Africa.
    Keita ML; Kaba A; Telly Diallo I; Kesso Bah M; Sagno M; Goumane A; Bouam A; Drancourt M
    Am J Trop Med Hyg; 2023 Jan; 108(1):221-226. PubMed ID: 36509061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans.
    Warryn L; Pluschke G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0087021. PubMed ID: 34662181
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.